Filing Details
- Accession Number:
- 0001127602-20-023455
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-08-12 16:36:30
- Reporting Period:
- 2020-07-28
- Accepted Time:
- 2020-08-12 16:36:30
- Original Submission Date:
- 2020-07-29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
794172 | Meridian Bioscience Inc | VIVO | In Vitro & In Vivo Diagnostic Substances (2835) | 310888197 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1432665 | Iii P Anthony Bihl | 3471 River Hills Drive Cincinnati OH 45244 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-08-11 | 5,000 | $17.99 | 5,851 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Acquisiton | 2020-07-28 | 4,595 | $0.00 | 4,595 | $23.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,595 | 2030-07-28 | No | 4 | A | Direct |
Footnotes
- This $23.50 Exercise Price serves to correct/replace the $8.7058 that was incorrectly reflected on the original Form 4 filed July 29, 2020.
- These options awarded under the 2012 Stock Incentive Plan vest 25% every 45 days from the date of grant.